Subdural Hematoma: Review of Diagnosis and Management
Monday, May 19, 2025
3:30 PM – 4:30 PM
CE: 1.00 AAPA Category 1 CME
No relevant relationships with ineligible companies to disclose within the past 24 months.
Subdural hematoma is an increasingly common neurosurgical condition primarily afflicting patients over 65 years of age who are on antithrombotic and anticoagulant drugs. This session will review the pathophysiology of acute and chronic subdural hematoma, discuss the role of antithrombotic and anticoagulant drugs, and the spectrum of treatment options. A treatment plan for acute subdural hematoma will be presented. Recent advances in endovascular therapy for chronic subdural hematoma have made middle meningeal artery embolization an attractive adjunct or alternative to traditional burr hole craniotomies. Attendees should leave the session prepared to assist with the emergency department and hospital management of patients with this condition.
Learning Objectives:
At the conclusion of this session, participants should be able to:
Recognize common presenting features and risk factors for developing subdural hematoma (SDH)
Define the pathophysiology and diagnostic characteristics of SDH
Review the spectrum of acute and chronic SDH
Contemplate the impact of antithrombotic drugs on SDH